The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants
Open accessAbstract
BACKGROUND: Mendelian Randomization (MR) studies assess the causality of an exposure-disease association using genetic determinants [i.e. instrumental variables (IVs)] of the exposure. Power and IV strength requirements for MR studies using multiple genetic variants have not been explored. METHODS: We simulated cohort data sets consisting of a normally distributed disease trait, a normally distributed exposure, which affects this trait and a biallelic genetic variant that affects the exposure. We estimated power to detect an effect of exposure on disease for varying allele frequencies, effect sizes and samples sizes (using two-stage least squares regression on 10,000 data sets-Stage 1 is a regression of exposure on the variant. Stage 2 is a regression of disease on the fitted exposure). Similar analyses were conducted using multiple genetic variants (5, 10, 20) as independent or combined IVs. We assessed IV strength using the first-stage F statistic. RESULTS: Simulations of realistic scenarios indicate that MR studies will require large (n > 1000), often very large (n > 10,000), sample sizes. In many cases, so-called 'weak IV' problems arise when using multiple variants as independent IVs (even with as few as five), resulting in biased effect estimates. Combining genetic factors into fewer IVs results in modest power decreases, but alleviates weak IV problems. Ideal methods for combining genetic factors depend upon knowledge of the genetic architecture underlying the exposure. CONCLUSIONS: The feasibility of well-powered, unbiased MR studies will depend upon the amount of variance in the exposure that can be explained by known genetic factors and the 'strength' of the IV set derived from these genetic factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · Technometrics · doi:10.1198/tech.2005.s303 · Cited by 17,923
Testing for Weak Instruments in Linear IV Regression
Stock, J. H., & Yogo, M. (2005) · Identification and Inference for Econometric Models · doi:10.1017/cbo9780511614491.006 · Cited by 7,211
Instrumental Variables Regression with Weak Instruments
Staiger, D., & Stock, J. (1994) · doi:10.3386/t0151 · Cited by 5,302
Draper, N. R., & Smith, H. (1998) · Wiley Series in Probability and Statistics · doi:10.1002/9781118625590 · Cited by 5,024
Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
Lawlor, D. A., Harbord, R. M., Sterne, J. A. C., Timpson, N., & Davey Smith, G. (2008) · Statistics in Medicine · doi:10.1002/sim.3034 · Cited by 4,618
A Survey of Weak Instruments and Weak Identification in Generalized Method of Moments
Stock, J. H., Wright, J. H., & Yogo, M. (2002) · Journal of Business & Economic Statistics · doi:10.1198/073500102288618658 · Cited by 4,274
Identification and estimation of local average treatment effects
Imbens, G. W., & Angrist, J. D. (1994) · Econometrica · doi:10.2307/2951620 · Cited by 4,101
Gunst, R. F. (1999) · Technometrics · doi:10.1080/00401706.1999.10485680 · Cited by 4,002
Bound, J., Jaeger, D. A., & Baker, R. M. (1995) · Journal of the American Statistical Association · doi:10.1080/01621459.1995.10476536 · Cited by 3,618
Identification and Estimation of Local Average Treatment Effects
Angrist, J., & Imbens, G. (1995) · National Bureau of Economic Research · doi:10.3386/t0118 · Cited by 2,808
Cited by
Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Burgess, S., Butterworth, A., & Thompson, S. G. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21758 · Cited by 6,050
Avoiding bias from weak instruments in Mendelian randomization studies
Burgess, S., Thompson, S. G., & CRP CHD Genetics Collaboration (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr036 · Cited by 3,952
Burgess, S., Bowden, J., Fall, T., Ingelsson, E., & Thompson, S. G. (2017) · Epidemiology · doi:10.1097/ede.0000000000000559 · Cited by 2,017
Calculating statistical power in Mendelian randomization studies.
Brion, M.-J. A., Shakhbazov, K., & Visscher, P. M. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt179 · Cited by 1,751
Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome
Greco M, F. D., Minelli, C., Sheehan, N. A., & Thompson, J. R. (2015) · Statistics in Medicine · doi:10.1002/sim.6522 · Cited by 1,700
“However, the use of multiple independent genetic instruments not only increases the power of the MR analysis [10], but it also allows investigation of pleiotropy [6, 12].”
BackgroundPierce, B. L., & Burgess, S. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt084 · Cited by 1,389
“It is well known that traditional “complete-data” IV estimators are biased towards the confounded association and that bias is most severe when the IV is weak (7, 14).”
BackgroundMethodInfluentialSelf-citationUsing multiple genetic variants as instrumental variables for modifiable risk factors
Palmer, T. M., Lawlor, D. A., Harbord, R. M., Sheehan, N. A., Tobias, J. H., Timpson, N. J., Smith, G. D., & Sterne, J. A. (2012) · Statistical Methods in Medical Research · doi:10.1177/0962280210394459 · Cited by 1,289
Vimaleswaran, K. S., Berry, D. J., Lu, C., Tikkanen, E., Pilz, S., Hiraki, L. T., Cooper, J. D., Dastani, Z., Li, R., Houston, D. K., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001383 · Cited by 1,046
Burgess, S. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu005 · Cited by 636
Methodological Challenges in Mendelian Randomization
VanderWeele, T. J., Tchetgen Tchetgen, E. J., Cornelis, M., & Kraft, P. (2014) · Epidemiology · doi:10.1097/ede.0000000000000081 · Cited by 555
Self-citationMendelian Randomization: New Applications in the Coming Age of Hypothesis-Free Causality
Evans, D. M., & Davey Smith, G. (2015) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090314-050016 · Cited by 528
Use of allele scores as instrumental variables for Mendelian randomization
Burgess, S., & Thompson, S. G. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt093 · Cited by 452
Selecting instruments for Mendelian randomization in the wake of genome-wide association studies.
Swerdlow, D. I., Kuchenbaecker, K. B., Shah, S., Sofat, R., Holmes, M. V., White, J., Mindell, J. S., Kivimaki, M., Brunner, E. J., Whittaker, J. C., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw088 · Cited by 387
Li, X., Meng, X., Timofeeva, M., Tzoulaki, I., Tsilidis, K. K., Ioannidis, P. A., Campbell, H., & Theodoratou, E. (2017) · BMJ · doi:10.1136/bmj.j2376 · Cited by 385
Emdin, C. A., Khera, A. V., Natarajan, P., Klarin, D., Zekavat, S. M., Hsiao, A. J., & Kathiresan, S. (2017) · JAMA · doi:10.1001/jama.2016.21042 · Cited by 378
Kim, M. S., Kim, W. J., Khera, A. V., Kim, J. Y., Yon, D. K., Lee, S. W., Shin, J. I., & Won, H.-H. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab454 · Cited by 378
The use of two-sample methods for Mendelian randomization analyses on single large datasets
Minelli, C., Del Greco M., F., van der Plaat, D. A., Bowden, J., Sheehan, N. A., & Thompson, J. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyab084 · Cited by 328
Hu, Y., Shmygelska, A., Tran, D., Eriksson, N., Tung, J. Y., & Hinds, D. A. (2016) · Nature Communications · doi:10.1038/ncomms10448 · Cited by 321
Statistical methods for Mendelian randomization in genome-wide association studies: A review
Boehm, F. J., & Zhou, X. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.05.015 · Cited by 318
Mendelian randomization: where are we now and where are we going?
Burgess, S., Timpson, N. J., Ebrahim, S., & Davey Smith, G. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv108 · Cited by 304
Xu, Q., Ni, J.-J., Han, B.-X., Yan, S.-S., Wei, X.-T., Feng, G.-J., Zhang, H., Zhang, L., Li, B., & Pei, Y.-F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.746998 · Cited by 295
Genome-wide association studies of obesity and metabolic syndrome
Fall, T., & Ingelsson, E. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.08.018 · Cited by 294
Glymour, M. M., Tchetgen Tchetgen, E. J., & Robins, J. M. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr323 · Cited by 292
“With multiple genetic IVs, it may be possible to combine instruments to develop more precise estimates and stronger overidentification tests (10, 32, 33).”
Advancing the use of genome-wide association studies for drug repurposing
Reay, W. R., & Cairns, M. J. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00387-z · Cited by 283
Kidney damage causally affects the brain cortical structure: A Mendelian randomization study
Chen, X., Kong, J., Pan, J., Huang, K., Zhou, W., Diao, X., Cai, J., Zheng, J., Yang, X., Xie, W., et al. (2021) · eBioMedicine · doi:10.1016/j.ebiom.2021.103592 · Cited by 267
Kappelmann, N., Arloth, J., Georgakis, M. K., Czamara, D., Rost, N., Ligthart, S., Khandaker, G. M., & Binder, E. B. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3436 · Cited by 266
Perry, B. I., Upthegrove, R., Kappelmann, N., Jones, P. B., Burgess, S., & Khandaker, G. M. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.07.009 · Cited by 187
Serum Iron Levels and the Risk of Parkinson Disease: A Mendelian Randomization Study
Pichler, I., Del Greco M., F., Gögele, M., Lill, C. M., Bertram, L., Do, C. B., Eriksson, N., Foroud, T., Myers, R. H., PD GWAS Consortium, et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001462 · Cited by 173
Taylor, A. E., Davies, N. M., Ware, J. J., VanderWeele, T., Smith, G. D., & Munafò, M. R. (2014) · Economics & Human Biology · doi:10.1016/j.ehb.2013.12.002 · Cited by 166
Self-citationThe many weak instruments problem and Mendelian randomization
Davies, N. M., von Hinke Kessler Scholder, S., Farbmacher, H., Burgess, S., Windmeijer, F., & Smith, G. D. (2015) · Statistics in Medicine · doi:10.1002/sim.6358 · Cited by 140
“This is a concern in applications using multiple genetic variants as instruments, because each variant is typically weakly associated with the exposure of interest [13–16].”
MethodBrower, M. A., Hai, Y., Jones, M. R., Guo, X., Chen, Y. D. I., Rotter, J. I., Krauss, R. M., Legro, R. S., Azziz, R., & Goodarzi, M. O. (2019) · Human Reproduction · doi:10.1093/humrep/dey343 · Cited by 115
Lawlor, D. A. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dys209 · Cited by 114
Genetic evidence that carbohydrate-stimulated insulin secretion leads to obesity
Astley, C. M., Todd, J. N., Salem, R. M., Vedantam, S., Ebbeling, C. B., Huang, P. L., Ludwig, D. S., Hirschhorn, J. N., & Florez, J. C. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.280727 · Cited by 86
Herpesvirus infections and Alzheimer's disease: a mendelian randomization study
Huang, S.-Y., Yang, Y.-X., Kuo, K., Li, H.-Q., Shen, X.-N., Chen, S.-D., Cui, M., Tan, L., Dong, Q., & Yu, J.-T. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00905-5 · Cited by 82
Minică, C. C., Dolan, C. V., Boomsma, D. I., de Geus, E., & Neale, M. C. (2018) · Behavior Genetics · doi:10.1007/s10519-018-9904-4 · Cited by 80
Jordan, D. M., Verbanck, M., & Do, R. (2019) · Genome Biology · doi:10.1186/s13059-019-1844-7 · Cited by 73
Silverwood, R. J., Holmes, M. V., Dale, C. E., Lawlor, D. A., Whittaker, J. C., Smith, G. D., Leon, D. A., Palmer, T., Keating, B. J., Zuccolo, L., et al. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu187 · Cited by 66
Genomic variation in educational attainment modifies Alzheimer disease risk
Raghavan, N. S., Vardarajan, B., & Mayeux, R. (2019) · Neurology Genetics · doi:10.1212/nxg.0000000000000310 · Cited by 33
Daghlas, I., Guo, Y., & Chasman, D. I. (2020) · European Journal of Neurology · doi:10.1111/ene.14111 · Cited by 32
Zhang, L., Zhuang, Z., Zhang, G., Huang, T., & Fan, D. (2022) · BMC Neurology · doi:10.1186/s12883-021-02522-z · Cited by 31
“The IVs (F statistic > 10) for all the exposures were sufficiently informative [23].”
BackgroundConstrained instruments and their application to Mendelian randomization with pleiotropy
Jiang, L., Oualkacha, K., Didelez, V., Ciampi, A., Rosa‐Neto, P., Benedet, A. L., Mathotaarachchi, S., Richards, J. B., Greenwood, C. M. T., & Initiative, A. F. T. A. D. N. (2019) · Genetic Epidemiology · doi:10.1002/gepi.22184 · Cited by 23
“However, weighted scores usually also reduce the power (sensitivity) of MR studies (Pierce et al., 2010; Palmer et al., 2012) and require all instruments to be valid.”
Gut microbiota and sepsis and sepsis-related death: a Mendelian randomization investigation
Shang, W., Zhang, S., Qian, H., Huang, S., Li, H., Liu, J., & Chen, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1266230 · Cited by 23
Diemer, E. W., Labrecque, J., Tiemeier, H., & Swanson, S. A. (2020) · Epidemiology · doi:10.1097/ede.0000000000001126 · Cited by 19
Genetic variants predisposing to an increased risk of kidney stone disease
Lovegrove, C. E., Goldsworthy, M., Haley, J., Smelser, D., Gorvin, C., Hannan, F. M., Mahajan, A., Suri, M., Sadeghi-Alavijeh, O., Moochhala, S. H., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186915 · Cited by 18
Impact of loss-of-function in angiopoietin-like 4 on the human phenome
Gagnon, E., Bourgault, J., Gobeil, É., Thériault, S., & Arsenault, B. J. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117558 · Cited by 17
Su, C.-Y., van der Graaf, A., Zhang, W., Jang, D.-K., Selber-Hnatiw, S., Yang, T.-Y., Butler-Laporte, G., Liang, K. Y. H., Matsuda, F., Costanzo, M. C., et al. (2024) · doi:10.1101/2024.10.17.24315553 · Cited by 17
Zhan, H., Cammann, D., Cummings, J. L., Dong, X., & Chen, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06317-5 · Cited by 17
Wang, Z., Zhu, H., Chen, L., Gan, C., Min, W., Xiao, J., Zou, Z., & He, Y. (2024) · Journal of Attention Disorders · doi:10.1177/10870547241264660 · Cited by 4
Metadata
- Authors
- Pierce, B. L., Ahsan, H., & VanderWeele, T. J.
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-09-15
- Volume
- 40
- Issue
- 3
- Pages
- 740-752
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2112203259
- Cited by
- 1,836
- References
- 67
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.